Vijaya Diagnostic Centre Ltd Share Price

Description

• The Company was incorporated as Vijaya Diagnostic Centre Private Limited on 05 June 2002. Subsequently,the Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on 22 March 2021 and the name of the Company was changed to Vijaya Diagnostic Centre Limited on 26 March 2021.The company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations,basic and high-end radiology,nuclear medicine and related healthcare services. The company has a chain of over 78 diagnostic centres spread across 12 cities that offer Laboratory Services, Radiology & Imaging Services, Cardiology Services, Neurology Services & Gastroenterology Services. The company won the award of Best Diagnostic Centre of the Year- India from Times Healthcare Achievers 2019. During the FY2020,14,13,071, 0.001% Series A Compulsorily Convertible Preference Shares have been converted into 1 fully paid-up Equity Share of Rs. 10/- each and 3005, 001% Series B Compulsory Convertible Preference Shares have been converted into 3,005 fully paid up Equity Shares of Rs.10/- each. During the FY2021,the Company was awarded the Award of Excellence for leading from the front during the pandemic under the Leading Diagnostic Chain of the Year by Elets Technomedia Private Limited.The company also received the certificate of recognition from the Economic Times as one of the Best Healthcare Brands-2021. As on 31 March 2021,the company have 5 subsidiaries namely,Medinova Diagnostic Services Ltd,Docotrslab Medical Services Pvt Ltd,VDC Diagnostics(Karnataka)LLP,Namrata Diagnostic Centre Pvt Ltd and Medinova Millennium MRI Services,LLP. During the year 2020-21,after getting the approval of shareholders at the EGM held on 22 March 2021,the company sub-divided the face value of equity share from Rs 10 to Re 1. On 27 May 2021,the company has issued 5,66,47,736 bonus equity shares of face value Re. 1 each to its shareholders in the ratio of 5:4. The company came out with an Rs 1895.04-crore public issue during the month of September 2021, comprised 35688064 equity shares of Re 1 each at a price of Rs 531 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 14 September 2021.

• The Company was incorporated as Vijaya Diagnostic Centre Private Limited on 05 June 2002. Subsequently,the Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on 22 March 2021 and the name of the Company was changed to Vijaya Diagnostic Centre Limited on 26 March 2021.The company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations,basic and high-end radiology,nuclear medicine and related healthcare services. The company has a chain of over 78 diagnostic centres spread across 12 cities that offer Laboratory Services, Radiology & Imaging Services, Cardiology Services, Neurology Services & Gastroenterology Services. The company won the award of Best Diagnostic Centre of the Year- India from Times Healthcare Achievers 2019. During the FY2020,14,13,071, 0.001% Series A Compulsorily Convertible Preference Shares have been converted into 1 fully paid-up Equity Share of Rs. 10/- each and 3005, 001% Series B Compulsory Convertible Preference Shares have been converted into 3,005 fully paid up Equity Shares of Rs.10/- each. During the FY2021,the Company was awarded the Award of Excellence for leading from the front during the pandemic under the Leading Diagnostic Chain of the Year by Elets Technomedia Private Limited.The company also received the certificate of recognition from the Economic Times as one of the Best Healthcare Brands-2021. As on 31 March 2021,the company have 5 subsidiaries namely,Medinova Diagnostic Services Ltd,Docotrslab Medical Services Pvt Ltd,VDC Diagnostics(Karnataka)LLP,Namrata Diagnostic Centre Pvt Ltd and Medinova Millennium MRI Services,LLP. During the year 2020-21,after getting the approval of shareholders at the EGM held on 22 March 2021,the company sub-divided the face value of equity share from Rs 10 to Re 1. On 27 May 2021,the company has issued 5,66,47,736 bonus equity shares of face value Re. 1 each to its shareholders in the ratio of 5:4. The company came out with an Rs 1895.04-crore public issue during the month of September 2021, comprised 35688064 equity shares of Re 1 each at a price of Rs 531 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 14 September 2021.